Back

Impact of levosimendan in the renal function of heart failure patients: data from a 10-year cohort

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Acute Heart Failure– Treatment Pharmacotherapy HFA Premium Access Heart Failure 2018

12 More presentations in this session

Presentation thumbnail
Effect of serelaxin on worsening heart failure when added to standard therapy in European patients with acute heart failure: Results from the RELAX-AHF-EU study
Presentation thumbnail
Targeted interventions reducing late maternal death due to heart failure
Doctor F. Azibani (Rondebosch, ZA)
Abstract
Presentation thumbnail
Association between high-dose spironolactone and decongestion in patients with acute heart failure
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Time to Furosemide Treatment and Outcomes in patients admitted for Acute Heart Failure
Doctor D. Roque (Amadora, PT)
Abstract
Presentation thumbnail
Use of levosimendan in the real world over the last 10 years - what to expect?

Access the full session

Session thumbnail
Poster Session 1 - Acute Heart Failure– Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources